Monday, April 25, 2016

Bayer Q1 adj EBITDA up 16 percent on pharmaceuticals

FRANKFURT, April 26 (Reuters) - Germany drugmaker Bayer

reported 15.7 percent higher underlying core earnings

for the first quarter, boosted by prescription drugs such as eye

treatment Eylea.

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)